← Evidence map

ReviewJournal of clinical medicine2026

Eravacycline as a Novel Option for Treating Multidrug-Resistant Gram-Negative and Gram-Positive Bacterial Infections: A Narrative Review.

Aleksandra Złotowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Eravacycline as a Novel Option for Treating Multidrug-Resistant Gram-Negative and Gram-Positive Bacterial Infections: A Narrative Review. | Socratic